ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugEnable Biotech AG
Enable Biotech AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Enable Biotech is the development and manufacturing of cell and gene therapies (ATMPs) as well as exosome therapies for clinical trials. The company offers Contract Development and Manufacturing Organization (CDMO) services, including process development, clinical manufacturing, quality control, and regulatory support. Enable Biotech focuses on the needs of start-ups and small companies in the field of advanced therapies, providing flexible and cost-effective solutions for the production of cell and gene therapies.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

Enable Biotech AG

✓ Offered7
CDMO services for Cell & Gene Therapy
CDMO services for the development and clinical manufacture of cell, gene-modified cell, and exosome therapies, with CMC expertise, process development, and GMP production.
Clinical GMP manufacturing of cell therapies
Clinical GMP manufacturing of cell therapies, including production with PBMC, T cells, NK cells, iPSCs, MSC and HLSCs, as well as QC release testing.
Clinical GMP manufacturing of gene therapies
Clinical GMP manufacturing of gene therapies, with gene editing via viral vectors such as AAV and LVV or electroporation, as well as support for clinical development.
Clinical GMP manufacturing of exosome therapies
Clinical GMP manufacturing of exosome therapies, including development, production and characterization in the context of cell & gene therapy.
CMC and regulatory submission support
Preparation of CMC sections in regulatory submissions, with support for early clinical development programs and upcoming regulatory requirements.
Process development for manufacturing and QA
Joint development of manufacturing and QA processes with flexible collaboration and alignment to later in-house production.
GMP infrastructure for development and production
SwissMedic-accredited GMP facility with a development laboratory, GMP production room, and QC laboratories for R&D, manufacturing, QC release testing and environmental monitoring.
Trust & reputation

ranQ Trust Score of Enable Biotech AG: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 54% · As of October 2026

Enable Biotech AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Enable Biotech AG scores 67.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.50.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Enable Biotech AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Enable Biotech AG scores 11.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.11.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Enable Biotech AG reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Enable Biotech AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Enable Biotech AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Enable Biotech AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Enable Biotech AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Baarerstrasse 8
6300 Zug

At a glance

Legal form
Corporation
UID
CHE-461.204.999
Founded
2023 · 3 years
Last commercial register change
December 29, 2025
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    IB
    Iovance Biotherapeutics GmbH
    Zug
    AT
    Aurealis Therapeutics AG
    Zug
    SI
    Sarepta International Holdings GmbH
    Zug
    CA
    Cellis AG
    Zug
    PB
    Packgene Biotech AG
    Zug
    CT
    CRISPR Therapeutics AG
    Zug
    OT
    Orchard Therapeutics (Switzerland) GmbH
    Zug
    QP
    Quercis Pharma AG
    Zug